Compare SAWAI GROUP HOLDINGS Co., Ltd. with Similar Stocks
Dashboard
1
Poor long term growth as Operating profit has grown by an annual rate -5.16% of over the last 5 years
- NET PROFIT(Q) At JPY 654 MM has Grown at 309.28%
- ROCE(HY) Highest at 6.55%
- RAW MATERIAL COST(Y) Fallen by -5.37% (YoY)
2
With ROCE of 7.62%, it has a risky valuation with a 1.29 Enterprise value to Capital Employed
3
Below par performance in long term as well as near term
Stock DNA
Pharmaceuticals & Biotechnology
JPY 197,772 Million (Small Cap)
NA (Loss Making)
NA
0.00%
0.43
-0.70%
1.11
Revenue and Profits:
Net Sales:
46,812 Million
(Quarterly Results - Mar 2026)
Net Profit:
654 Million
Total Returns (Price + Dividend) 
TimePeriod
Price Return
Dividend Return
Total Return
3 Months
-28.64%
0%
-28.64%
6 Months
-32.46%
0%
-32.46%
1 Year
-10.02%
0%
-10.02%
2 Years
-74.45%
0%
-74.45%
3 Years
-55.45%
0%
-55.45%
4 Years
-61.24%
0%
-61.24%
5 Years
-67.8%
0%
-67.8%
SAWAI GROUP HOLDINGS Co., Ltd. for the last several years.
Risk Adjusted Returns v/s 
News
No Recent News for the Company
Announcements 
No announcement available
Corporate Actions 
No corporate action available
Quality key factors 
Factor
Value
Sales Growth (5y)
1.95%
EBIT Growth (5y)
-5.16%
EBIT to Interest (avg)
26.05
Debt to EBITDA (avg)
1.53
Net Debt to Equity (avg)
0.31
Sales to Capital Employed (avg)
0.65
Tax Ratio
31.26%
Dividend Payout Ratio
54.90%
Pledged Shares
0
Institutional Holding
0
ROCE (avg)
6.62%
ROE (avg)
4.67%
Valuation key factors
Factor
Value
P/E Ratio
NA (Loss Making)
Industry P/E
Price to Book Value
1.41
EV to EBIT
16.94
EV to EBITDA
16.94
EV to Capital Employed
1.29
EV to Sales
1.64
PEG Ratio
NA
Dividend Yield
NA
ROCE (Latest)
7.62%
ROE (Latest)
-0.70%
Technicals key factors
Indicator
Weekly
Monthly
MACD
Bearish
Mildly Bullish
RSI
No Signal
No Signal
Bollinger Bands
Bearish
Bearish
Moving Averages
Bearish (Daily)
KST
Bearish
Mildly Bullish
Dow Theory
Bearish
Bearish
OBV
Mildly Bearish
Mildly Bearish
Shareholding Snapshot
No data for shareholding present.
Shareholding Compare (%holding) 
No data for shareholding present.
Quarterly Results Snapshot (Consolidated) - Mar'26 - QoQ
Mar'26
Dec'25
Change(%)
Net Sales
46,812.00
56,021.00
-16.44%
Operating Profit (PBDIT) excl Other Income
243.00
7,566.00
-96.79%
Interest
529.00
589.00
-10.19%
Exceptional Items
0.00
0.00
Consolidate Net Profit
654.00
4,875.00
-86.58%
Operating Profit Margin (Excl OI)
5.20%
135.10%
-12.99%
USD in Million.
Net Sales
QoQ Growth in quarter ended Mar 2026 is -16.44% vs 13.56% in Dec 2025
Consolidated Net Profit
QoQ Growth in quarter ended Mar 2026 is -86.58% vs 323.54% in Dec 2025
Annual Results Snapshot (Consolidated) - Mar'26
Mar'26
Mar'25
Change(%)
Net Sales
201,676.00
189,024.00
6.69%
Operating Profit (PBDIT) excl Other Income
36,352.00
35,481.00
2.45%
Interest
1,757.00
1,039.00
69.10%
Exceptional Items
-3,979.00
-16,757.00
76.25%
Consolidate Net Profit
11,536.00
2,173.00
430.88%
Operating Profit Margin (Excl OI)
100.90%
107.10%
-0.62%
USD in Million.
Net Sales
YoY Growth in year ended Mar 2026 is 6.69% vs 6.88% in Mar 2025
Consolidated Net Profit
YoY Growth in year ended Mar 2026 is 430.88% vs -82.86% in Mar 2025
About SAWAI GROUP HOLDINGS Co., Ltd. 
SAWAI GROUP HOLDINGS Co., Ltd.
Pharmaceuticals & Biotechnology
No Details Available.
Company Coordinates 
No Company Details Available






